A Study of Equfina® on the Incidences of Adverse Drug Reactions in Participants With Parkinson's Disease (Including Participants With Hepatic Impairment)
Clinical trial NCT04724109 · COMPLETED
Trial details
- NCT number
- NCT04724109
- Sponsor
- Eisai Co., Ltd.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-10-14
- Primary completion
- 2022-10-13
- Enrollment
- 1088
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.